"Carcinogenesis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
| Descriptor ID |
D063646
|
| MeSH Number(s) |
C04.697.098 C23.550.727.098
|
| Concept/Terms |
Carcinogenesis- Carcinogenesis
- Carcinogeneses
- Tumorigenesis
- Tumorigeneses
- Oncogenesis
- Oncogeneses
|
Below are MeSH descriptors whose meaning is more general than "Carcinogenesis".
Below are MeSH descriptors whose meaning is more specific than "Carcinogenesis".
This graph shows the total number of publications written about "Carcinogenesis" by people in this website by year, and whether "Carcinogenesis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 33 | 32 | 65 |
| 2018 | 23 | 45 | 68 |
| 2019 | 14 | 14 | 28 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Carcinogenesis" by people in Profiles.
-
The risk of pancreatic adenocarcinoma following SARS-CoV family infection. Sci Rep. 2021 06 21; 11(1):12948.
-
Topical hypochlorous acid (HOCl) blocks inflammatory gene expression and tumorigenic progression in UV-exposed SKH-1 high risk mouse skin. Redox Biol. 2021 09; 45:102042.
-
Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism. Virus Res. 2021 08; 301:198464.
-
The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment. OMICS. 2021 06; 25(6):358-371.
-
COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response. Sci Rep. 2021 03 04; 11(1):5228.
-
Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine. Int J Mol Sci. 2021 Feb 18; 22(4).
-
Origins and Evolution of Photocarcinogenesis Action Spectra, Including Germicidal UVC†. Photochem Photobiol. 2021 05; 97(3):477-484.
-
Low dose radiation therapy for COVID-19: Effective dose and estimation of cancer risk. Radiother Oncol. 2020 12; 153:289-295.
-
RNA-dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID-19. Cancer Sci. 2020 Nov; 111(11):3976-3984.
-
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer. Future Oncol. 2020 Sep; 16(27):2029-2033.